Caricamento...
Targeting angiogenesis for liver cancer: Past, present, and future
Liver cancer, mostly hepatocellular carcinoma (HCC), is the second leading cause of cancer mortality globally. Most patients were diagnosed at an advanced stage, and systemic therapy is the standard of care. All the approved systemic therapies for HCC are molecular targeted therapies with anti-angio...
Salvato in:
| Pubblicato in: | Genes Dis |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Chongqing Medical University
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7452391/ https://ncbi.nlm.nih.gov/pubmed/32884987 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gendis.2020.03.010 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|